Gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), has been reported with GLP-1 receptor agonists as a class
Animal studies even really promising ones dont automatically translate to human safety data, and compounding pharmacies were scaling up production of a substance that had never cleared that bar
Thanks to its cytoprotective effects in the GI tract , BPC-157 is being explored as a therapy for inflammatory bowel diseases like Crohns disease and ulcerative colitis
While the vast majority are compliant and very safe, he said, the small number of spas that allow unauthorized procedures and employ unlicensed workers keeps him up at night. There is a bit of an underbelly to this industry, where youve got folks who should not be doing the treatment that theyre doing, Thiersch said
Thus, the PRMR Hospital Recommendation Group did not reach consensus and did not recommend including this measure in the ASCQR Program either with or without conditions
Many patients maintain these improvements for months after completing their protocol
